Literature DB >> 23071860

Early impaired β-cell function in chinese women with polycystic ovary syndrome.

Tao Tao1, Shengxian Li, Aimin Zhao, Xiuyin Mao, Wei Liu.   

Abstract

BACKGROUND: The pathogenic factors that account for the development of diabetes condition in Chinese women with polycystic ovary syndrome (PCOS) remain elusive. AIM: To clarify the pathogenic features by evaluating the levels of insulin sensitivity and β cell function in these women with PCOS, either separately or by using of a disposition indexes (DIs).
METHODS: Cross-sectional study involving 137 Chinese women with PCOS and 123 normal women were examined by anthropometry, lipid profile, sex hormone, high-sensitivity C reactive protein, oral glucose tolerance tests and insulin tolerance tests.
RESULTS: After controlling for BMI status, the Matsuda Index was significantly lower in women with PCOS in comparison to those of normal women (p<0.000). The early phase of insulin secretion (insulinogenic index) remained significantly lower in lean women with PCOS(LP) than those of both lean and obese women of control group (p=0.007, and p = 0.01, respectively). The mean HOMA-F values were significantly lower (p =0.045) in obese women with PCOS (OP) than those of BMI-matched women. Further, all DIs derived from non-fasting state indexes in women with PCOS were significantly lower than those of BMI-matched control women (p<0.001 for all). Lastly, DIs derived from fasting states indexes in OP were significantly lower than those of LP.
CONCLUSION: Early impaired β cell function was detected in both LP and OP. However, more serious primary defect in insulin action was detected in LP compared to OP. These findings imply that early screening and intervention for PCOS would be therapeutic for Chinese women.

Entities:  

Keywords:  Polycystic ovary syndrome; early phase secretion of insulin; insulin resistance

Mesh:

Substances:

Year:  2012        PMID: 23071860      PMCID: PMC3466975     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.

Authors:  L C Morin-Papunen; I Vauhkonen; R M Koivunen; A Ruokonen; J S Tapanainen
Journal:  Hum Reprod       Date:  2000-06       Impact factor: 6.918

2.  Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.

Authors:  S A Arslanian; V D Lewy; K Danadian
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

3.  Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes.

Authors:  R M Koivunen; J Juutinen; I Vauhkonen; L C Morin-Papunen; A Ruokonen; J S Tapanainen
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

4.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

Review 5.  The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes.

Authors:  R N Bergman; D T Finegood; S E Kahn
Journal:  Eur J Clin Invest       Date:  2002-06       Impact factor: 4.686

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.

Authors:  J Adams; S Franks; D W Polson; H D Mason; N Abdulwahid; M Tucker; D V Morris; J Price; H S Jacobs
Journal:  Lancet       Date:  1985 Dec 21-28       Impact factor: 79.321

8.  Defects in beta-cell function in functional ovarian hyperandrogenism.

Authors:  N M O'Meara; J D Blackman; D A Ehrmann; R B Barnes; J B Jaspan; R L Rosenfield; K S Polonsky
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

9.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

Authors:  H S Seltzer; E W Allen; A L Herron; M T Brennan
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

10.  Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN).

Authors:  Javier I Torréns; Joan Skurnick; Amy L Davidow; Stanley G Korenman; Nanette Santoro; Maria Soto-Greene; Norman Lasser; Gerson Weiss
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

View more
  7 in total

1.  Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.

Authors:  Danalea V Skarra; Angelina Hernández-Carretero; Alissa J Rivera; Arya R Anvar; Varykina G Thackray
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

2.  Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study.

Authors:  Tao Tao; Yi Zhang; Yu-Chen Zhu; Jia-Rong Fu; Yu-Ying Wang; Jie Cai; Jing-Yu Ma; Yu Xu; Yi-Ning Gao; Yun Sun; WuQiang Fan; Wei Liu
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

3.  Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.

Authors:  Do Kyeong Song; Young Sun Hong; Yeon-Ah Sung; Hyejin Lee
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

4.  Tanshinone for polycystic ovary syndrome: A protocol of systematic review and meta-analysis.

Authors:  Yijiao Yang; Yue Xia; Xia Peng; Jiani Xie; Honglin Liu; Xiaorong Ni
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

5.  The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.

Authors:  Shaimaa Aboeldalyl; Cathryn James; Emaduldin Seyam; Emad Moussa Ibrahim; Hossam El-Din Shawki; Saad Amer
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

6.  Developmental programming of polycystic ovary syndrome (PCOS): prenatal androgens establish pancreatic islet α/β cell ratio and subsequent insulin secretion.

Authors:  S Ramaswamy; C Grace; A A Mattei; K Siemienowicz; W Brownlee; J MacCallum; A S McNeilly; W C Duncan; M T Rae
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

7.  Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.

Authors:  Tao Tao; Peihong Wu; Yuying Wang; Wei Liu
Journal:  BMC Endocr Disord       Date:  2018-02-27       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.